Jeuveau You See Me
UNAPOLOGETICALLY YOU, FEWER FROWN LINES
Jeuveau temporarily makes moderate to severe frown lines look better in adults.
Right arrow
UNAPOLOGETICALLY YOU, FEWER FROWN LINES
Jeuveau temporarily makes moderate to severe frown lines look better in adults.
Right arrow

4 REASONS TO CHOOSE Jeuveau

Single vial of JeuveauEvolus Model
A Natural Look
Jeuveau is a precise and targeted wrinkle treatment that diminishes frown lines.
Fast Acting +
Long Lasting
Results can start in as little as two days* and can last for up to four months. On average, people treated with Jeuveau receive three treatments per year.
Preferred
People treated with Jeuveau reported high satisfaction with their treatment experience – and 74% of people surveyed prefer Jeuveau.†
Recommended
9 out of 10 people treated with Jeuveau said they would recommend it to a family member or friend.†

Skincare & Beauty

Trends and Advice
Read the Beauty Blog
Gradient arrow

See The
results

Over 1 million Jeuveau treatments since 2019.
Fastest growing injectable frown line treatment
Floating portait. David.Floating portait. Sarah.Floating portait. Soo Youn.
Floating portait frame.
Model smilingModel smiling
Floating portait frame.
Model smilingModel smiling
Day 0 & Day 30
Day 2
Day 30
Day 120
Day 0 & Day 30
Soo Youn
Soo Youn
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Soo YounSoo Youn
See More Results
Right arrow
At maximum frown. Actual patient. Results may vary.
See More Results
Right arrow
At maximum frown. Jeuveau® patient. Individual results may vary.
Evolus Model

BYE,
FROWN LINES.

HELLO,
Jeuveau!

Jeuveau NEAR ME
Right arrow
Jeuveau is a prescription treatment injected into muscles to temporarily improve the look of moderate to severe frown lines between the eyebrows in adults.

AS SEEN IN

Jeuveau NEAR ME
Right arrow
1. Jeuveau (package insert). Newport Beach, CA :Evolus, Inc. 2020
2. Rzany B. A multicenter, randomized, double-blind, placebo-controlled, single-dose, phase III, non-inferiority study comparing prabotulinumtoxinA and onabotulinumtoxinA for the treatment of moderate to severe glabellar lines in adult patients. About 50% of patients begin showing improvement after two days (≥1-grade improvement by physician assessment). Aesthet Surg J. 2020;40(4):413-429.
3. Beer K. Efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in adult subjects: results from identical phase III studies. Most patients (~69%) achieve complete results by day 30 (≥2-grade improvement by physician and patient assessments). Dermatol Surg. 2019;45(11):1381-1393
4. Patient survey data collected 30 days after treatment (n=9151); slightly to extremely satisfied on a 5-point rating scale. Jeuveau Experience Treatment (J.E.T.) Interim Data Report, 12/16/2019; Evolus, Inc.